Perform Another (Advanced) Search

1.  Study Posting (2246) Trial #70983, Lymphomas, Duarte, CA
...Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents with Newly Diagnosed Intermediate Risk Hodgkin Disease You have/Your child has been asked to participate in this research study because you ...
View Page

2.  CenterWatch: New Medical Therapies in Disease Category (675), Hodgkin's Disease
...a phase II trial of everolimus (Afinitor) for the treatment of non-Hodgkins lymphoma and Hodgkins disease. This open-label, single-arm study enrolled 145 subjects with relapsed/refractory aggressive or indolent ...
View Page

3.  CenterWatch: New Medical Therapies in Disease Category (203), Non-Hodgkin's Lymphoma
...a phase II trial of everolimus (Afinitor) for the treatment of non-Hodgkins lymphoma and Hodgkins disease. This open-label, single-arm study enrolled 145 subjects with relapsed/refractory aggressive or indolent ...
View Page

4.  CenterWatch: Clinical Trials in Category (95) Lymphomas
...Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents with Newly Diagnosed Intermediate Risk Hodgkin Disease Duarte : City of Hope New! Obtaining Leukapheresed Peripheral Blood Mononuclear Cells from Healthy Volunteer Donors ...
View Page

5.  CenterWatch Clinical Research Profile (2246) Trial #1369, City of Hope, Duarte, CA
...Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents with Newly Diagnosed Intermediate Risk Hodgkin Disease • COG ALTE03N1: Key Adverse Events After Childhood Cancer • COG ALTE03N1: Key Adverse Events After Childhood ...
View Page